Who owns UNICYCIVE THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Unicycive Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Unicycive Therapeutics stock

Who bought or sold UNICYCIVE THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vivo Capital 1.8M $7.8M 57% Sep 2025
 View chart
Octagon Capital Advisors 1.0M $4.4M 0% Sep 2025
 View chart
Nantahala Capital Management 939k $4.1M 0% Sep 2025
 View chart
Dr. Jeffrey R. Jay, M.D. 797k $3.5M 0% Sep 2025
 View chart
Vanguard Group 659k $2.9M 9% Sep 2025
 View chart
Logos Global Management 474k $2.1M 0% Sep 2025
 View chart
Geode Capital Management 126k $548k 114% Sep 2025
 View chart
Squarepoint Ops 117k $512k 100% Sep 2025
 View chart
Longwood Capital Partners 60k $262k -5% Sep 2025
 View chart
State Street Corporation 55k $239k 338% Sep 2025
 View chart
Goldman Sachs Group 45k $197k 100% Sep 2025
 View chart
Citadel Advisors 42k $182k 100% Sep 2025
 View chart
XTX Topco 38k $165k 100% Sep 2025
 View chart
BlackRock 36k $159k 100% Sep 2025
 View chart
Northern Trust 33k $143k 203% Sep 2025
 View chart
Chicago Partners Investment 27k $127k 100% Sep 2025
 View chart
Cubist Systematic Strategies 24k $104k 100% Sep 2025
 View chart
UBS Group 5.4k $24k 100% Sep 2025
 View chart
Morgan Stanley 1.0k $4.8k 100% Jun 2025
 View chart
SBI Securities 560.00 $2.4k 1% Sep 2025
 View chart
Rockefeller Capital Management 500.00 $2.2k 100% Sep 2025
 View chart
TFC Financial Management 300.00 $1.3k 100% Sep 2025
 View chart
Fortitude Family Office 107.00 $467.001500 100% Sep 2025
 View chart
Harbour Investments 100.00 $436.000000 0% Sep 2025
 View chart
Barclays 80.00 $349.000000 0% Sep 2025
 View chart
Bnp Paribas Arbitrage, Snc 55.00 $239.998000 100% Sep 2025
 View chart
Bogart Wealth 6.00 $25.999800 0% Sep 2025
 View chart
Danske Bank A/s 1.00 $4.000000 100% Sep 2025
 View chart

Who sold out of Unicycive Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Renaissance Technologies Jun 2025 12k $56k
Lazard Asset Management Jun 2025 12k $55k